Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes. [PDF]
Liao KM, Wu JY, Lai CC.
europepmc +1 more source
Five-year follow-up of incretin-based therapy in a patient with KCNJ11-related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction. [PDF]
Ohkuma T +4 more
europepmc +1 more source
From Weed Evolution to Crop Design: A Computational Blueprint for a Novel, Synergistic Herbicide-Resistant Allele in Wheat. [PDF]
Wang Y +6 more
europepmc +1 more source
Understanding Diabetes Distress: A Study of Contributing Factors Among Adults With Type 2 Diabetes in Rural East Godavari, Andhra Pradesh. [PDF]
Meka RJ +4 more
europepmc +1 more source
Identifying high-risk combinations of metformin during COVID-19. [PDF]
Dimnjaković J +5 more
europepmc +1 more source
Antibiotics and the Endocrine System: Mechanisms, Adverse Effects, and Clinical Implications. [PDF]
Grabarczyk Ł +4 more
europepmc +1 more source
Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk. [PDF]
Soga R +4 more
europepmc +1 more source
Screening of binding by antidiabetic drugs to normal vs AGE-modified human serum albumin through covalent immobilization and microscale affinity chromatography. [PDF]
Woolfork AG +3 more
europepmc +1 more source
The Impact of Polymers in Amorphous Solid Dispersion on the Bioavailability of Sulfonylureas and Meglitinides. [PDF]
Aulifa DL +8 more
europepmc +1 more source

